Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice

Lok S.S., Haider Y., Howell D., Stewart J.P., Hasleton P.S., Egan J.J.

Source: Eur Respir J 2002; 20: 1228-1232
Journal Issue: November
Disease area: Interstitial lung diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lok S.S., Haider Y., Howell D., Stewart J.P., Hasleton P.S., Egan J.J.. Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice. Eur Respir J 2002; 20: 1228-1232

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of influenza virus infection in lung fibrosis
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010


Influenza infection affects the degree of fibrosis and apoptosis in the bleomycin mouse model
Source: Annual Congress 2013 –Interesting research questions
Year: 2013

Epstein-Barr virus specific antibodies in patients with idiopathic pulmonary fibrosis and presence of EBV in respiratory tract: reactivation of infection?
Source: Eur Respir J 2005; 26: Suppl. 49, 333s
Year: 2005

Respiratory viral agents in cystic fibrosis
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005


Regulation of microRNAs in response to herpes simplex virus type-1 (HSV-1) infection in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013

The role of hepatitis C virus infections in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 333s
Year: 2005

Bleomycin induced lung fibrosis in mice is attenuated by a new somatostatin analog
Source: Annual Congress 2006 - Matrix remodelling at the interface of lung fibrosis and emphysema
Year: 2006


Pulmonary hypertension in human immunodeficiency virus infection
Source: Eur Respir J 2002; 20: Suppl. 38, 443s
Year: 2002

Interferon-γ pretreated human MSC show improved efficiency in humanized mice model of pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016

No association between Human herpes virus, Herpes virus Saimiri and idiopathic pulmonary fibrosis
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019

The role of viruses in the pathogenesis of pulmonary fibrosis
Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease
Year: 2021


TNF-mediated alveolar macrophage necroptosis drives disease pathogenesis during respiratory syncytial virus infection
Source: Eur Respir J, 57 (6) 2003764; 10.1183/13993003.03764-2020
Year: 2021



FGF-9 overexpression prevents pleural fibrosis induced by intra-pleural adenovirus injection in mice
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015


Pulmonary alveolar proteinosis associated with Epstein-Barr virus infection
Source: Eur Respir J 2010; 36: 1214-1216
Year: 2010


Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis
Source: Eur Respir J 2012; 39: 297-304
Year: 2012



The role of expression of TLR 4 in bleomycin-induced pulmonary fibrosis in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013


High levels of Epstein-Barr virus in COPD
Source: Eur Respir J 2008; 31: 1221-1226
Year: 2008



The histological effects of interleukin-10 on mouse lung inflammation after recombinant Sendai virus vector transduction
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007


Viral infection drives tissue fibrosis in vitro
Source: Eur Respir J 2007; 30: Suppl. 51, 510s
Year: 2007